Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Artelo Biosciences, Inc. - Common Stock
(NQ:
ARTL
)
1.420
+0.110 (+8.40%)
Streaming Delayed Price
Updated: 1:22 PM EST, Jan 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Artelo Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Dow Dips 1%; Mustang Bio Shares Spike Higher
↗
July 07, 2025
Via
Benzinga
Topics
Stocks
Here are the top movers in Monday's session.
↗
July 07, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
July 07, 2025
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Recap: Artelo Biosciences Q4 Earnings
↗
March 25, 2024
Via
Benzinga
Recap: Artelo Biosciences Q3 Earnings
↗
November 13, 2023
Via
Benzinga
Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS
↗
July 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 07, 2025
Via
Benzinga
Which stocks are moving on Tuesday?
↗
July 01, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
July 01, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Tuesday?
↗
July 01, 2025
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Get insights into the top gainers and losers of Tuesday's pre-market session.
↗
July 01, 2025
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 01, 2025
Via
Benzinga
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
↗
July 01, 2025
Via
Benzinga
Synergy CHC Corp. (NASDAQ: SNYR) Secures Distribution Wins for FOCUSfactor® Supplements and Functional Beverages – More Stocks Inside
June 30, 2025
Via
AB Newswire
These stocks are moving in today's after hours session
↗
June 30, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Artelo Biosciences Stock Doubles After Positive Results In First Non-Opioid Pain Treatment Trial
↗
June 30, 2025
The company said that a multiple ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of ART26.12 with repeated dosing over time is expected to commence in the fourth quarter...
Via
Stocktwits
Crude Oil Moves Lower; Joby Aviation Shares Surge
↗
June 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 30, 2025
Via
Benzinga
Dow Gains Over 100 Points; Chicago PMI Weakens In June
↗
June 30, 2025
Via
Benzinga
Topics
Stocks
Why Is Micro-Cap Artelo Biosciences Stock Trading Higher On Monday?
↗
June 30, 2025
Artelo reports favorable Phase 1 results for its FABP5 inhibitor, showing strong safety data and dose-dependent absorption in 49 healthy participants.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 30, 2025
Via
Benzinga
This UnitedHealth Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
↗
June 11, 2025
Via
Benzinga
EXCLUSIVE: Artelo Biosciences' New Peer-Reviewed Research Shows Effectiveness Of Psoriasis Candidate In Animal Models
↗
April 28, 2025
Artelo Biosciences advances ART26.12 for psoriasis and CIPN, while ART27.13 shows early promise in cancer-related anorexia studies.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 14, 2025
Via
Benzinga
EXCLUSIVE: Artelo Biosciences Concludes First Cohort Of Healthy Volunteers Of FABP Inhibitor Program
↗
January 13, 2025
Artelo Biosciences advances its pipeline with ART26.12 for neuropathic pain and ART27.13 for cancer-related anorexia, targeting 2025 milestones.
Via
Benzinga
ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q2 2024
↗
August 13, 2024
ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q1 2024
↗
May 13, 2024
ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
ARTL Stock Earnings: Artelo Biosciences Misses EPS for Q4 2023
↗
March 25, 2024
ARTL stock results show that Artelo Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
March 06, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
